Thomas J. Marquez

No más puestos en curso

86 años

Finance

Health Technology

Perfil

Thomas J.
Marquez worked at Delsite, Inc. from 1987 to 2008, where he held the position of Director in 2008.
He also worked at Petrus Securities LP as the Head of Research.

Antiguos cargos conocidos de Thomas J. Marquez.

Empresas	Cargo	Fin
Delsite, Inc. Delsite, Inc. Pharmaceuticals: OtherHealth Technology DelSite, Inc. research-based, biopharmaceutical and consumer products company with a core technology based on naturally occurring complex carbohydrates. DelSite is developing its proprietary GelSite technology designed to provide controlled release of peptide and protein-based drugs. More than 130 patents protect its technology. It was incorporated in Texas in 1973, as Carrington Laboratories, Inc.	Director/Miembro de la Junta	19/10/2008
Petrus Securities LP Petrus Securities LP Investment ManagersFinance Petrus Securities LP is an investment management firm headquartered in Dallas, Texas. The firm was founded by H. Ross Perot and is a subsidiary of Perot Investments LP. Petrus Securities manages the assets of various clients.	Director de Investigación - Acciones	-

Ver el detalle de la experiencia de Thomas J. Marquez.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Thomas J. Marquez.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Petrus Securities LP Petrus Securities LP Investment ManagersFinance Petrus Securities LP is an investment management firm headquartered in Dallas, Texas. The firm was founded by H. Ross Perot and is a subsidiary of Perot Investments LP. Petrus Securities manages the assets of various clients.	Finance
Delsite, Inc. Delsite, Inc. Pharmaceuticals: OtherHealth Technology DelSite, Inc. research-based, biopharmaceutical and consumer products company with a core technology based on naturally occurring complex carbohydrates. DelSite is developing its proprietary GelSite technology designed to provide controlled release of peptide and protein-based drugs. More than 130 patents protect its technology. It was incorporated in Texas in 1973, as Carrington Laboratories, Inc.	Health Technology